Form 4 for ABOS Acumen Pharmaceuticals, Inc.
Accepted 2021-07-08 00:00:00 ET · period of report 2021-07-06 · accession 0001209191-21-046026 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-07-08 | 2021-07-06 | ABOS | Fountain Nathan B | Dir | P - Purchase | $16.00 | +6,250 | 6,250 | New | +$100.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-06 | P | A | 6,250 | $16.00 | 6,250 | D | — | — |